Skip to main content

Table 2 Univariate analysis for luminal types (ILC and IDC)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

 

DFS

OS

Variables

HR (95 % CI)

P-value

HR (95 % CI)

P-value

Age

    

50

1.0

 

1.0

 

  < 50

1.14(0.80–1.64)

0.455

1.17(0.65–2.11)

0.591

Menopause status

    

 Post

1.0

 

1.0

 

 Pre

1.06(0.75–1.51)

0.708

1.20(0.68–2.11)

0.513

Tumor size

    

  < 2

1.0

 

1.0

 

 2 ≤ T < 5

3.82(2.62–5.58)

 

6.08(3.19–11.57)

 

 5≥

8.24(4.72–14.39)

<0.001

11.81(4.74–29.42)

<0.001

Lymph node status

    

 Negative

1.0

 

1.0

 

 Positive

3.51(2.40–5.12)

<0.001

6.26(3.17–12.36)

<0.001

Pathology type(ILC,IDC)

    

 IDC

1.0

 

1.0

 

 ILC

2.06(1.18–3.60)

0.008

2.48(1.05–5.84)

0.030

Histological grade

    

 1

1.0

 

1.0

 

 2

1.98(1.19–3.31)

 

2.03(0.82–5.00)

 

 3

4.41(2.53–7.70)

<0.001

5.52(2.15–14.12)

<0.001

  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DFS disease free survival, OS overall survival, HR hazard ratio, 95 % CI 95 % confidence interval